Literature DB >> 9683824

Bone morphogenetic protein 2 suppresses the transformed phenotype and restores actin microfilaments of human lung carcinoma A549 cells.

A Tada1, T Nishihara, H Kato.   

Abstract

Bone morphogenetic protein 2 (BMP2) is a member of the transforming growth factor beta (TGFbeta) superfamily. Here we report a biological function of BMP2. Treatment of human lung carcinoma cell line, A549 cells with BMP2 resulted in inhibition of A549 cell growth in anchorage-dependent and independent growth conditions. Furthermore, BMP2 induced microfilament organization restoration in A549 cells. These changes were also observed in TGFbeta1-treated A549 cells. BMP2 and TGFbeta1 additionally suppressed the transformed phenotypes and restored actin microfilaments in A549 cells. In contrast, activin A, another member of the TGF superfamily did not induce these phenomena. It was also noted that the development of the microfilaments is almost proportional to the extent of the inhibition of cell growth in our system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683824     DOI: 10.3892/or.5.5.1137

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis.

Authors:  Martin Raida; Joachim H Clement; Russell D Leek; Kurosh Ameri; Roy Bicknell; Dietger Niederwieser; Adrian L Harris
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

2.  Global methylation profiling of lung cancer identifies novel methylated genes.

Authors:  Z Dai; R R Lakshmanan; W G Zhu; D J Smiraglia; L J Rush; M C Frühwald; R M Brena; B Li; F A Wright; P Ross; G A Otterson; C Plass
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

3.  Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients.

Authors:  Ying Ma; Lin Ma; Quan Guo; Shulan Zhang
Journal:  J Exp Clin Cancer Res       Date:  2010-06-30

4.  Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines.

Authors:  Elaine Langenfeld; Charles C Hong; Gandhi Lanke; John Langenfeld
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

5.  In vitro and in vivo studies on the effects of bone morphogenetic protein-7 on human kidney and lung tumor cells.

Authors:  Lee-Chuan C Yeh
Journal:  Int J Biomed Sci       Date:  2010-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.